1. Home
  2. PRME vs MAMA Comparison

PRME vs MAMA Comparison

Compare PRME & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.02

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$18.24

Market Cap

602.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
MAMA
Founded
2019
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Specialty Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
602.1M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
PRME
MAMA
Price
$3.02
$18.24
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$7.56
$19.00
AVG Volume (30 Days)
3.1M
523.7K
Earning Date
05-08-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
44.44
EPS
N/A
0.05
Revenue
$4,632,000.00
$95,420,129.00
Revenue This Year
$7.06
$31.09
Revenue Next Year
$47.01
$16.12
P/E Ratio
N/A
$366.20
Revenue Growth
55.28
95.54
52 Week Low
$2.67
$7.88
52 Week High
$6.94
$21.00

Technical Indicators

Market Signals
Indicator
PRME
MAMA
Relative Strength Index (RSI) 42.71 54.75
Support Level $2.74 $17.37
Resistance Level $3.60 $19.68
Average True Range (ATR) 0.18 0.77
MACD -0.02 0.01
Stochastic Oscillator 46.00 63.89

Price Performance

Historical Comparison
PRME
MAMA

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About MAMA Mama's Creations Inc.

Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

Share on Social Networks: